Condition:   Rheumatoid Arthritis
Interventions:   Drug: Remicade (infliximab);   Drug: SB2 (proposed biosimilar to infliximab)
Sponsors:   Samsung Bioepis Co., Ltd.;   Samsung Bioepis Co., Ltd.
Recruiting - verified September 2013